SDG indicator 3.b.3 - an analysis of its robustness and challenges for measuring access to medicines for children.

ABSTRACT:

Background

Sustainable Development Goal (SDG) indicator 3.b.3 monitors progress in medicines' accessibility for adults and has significant limitations when applying to medicines for children. An adapted indicator methodology was developed to fill this gap, but no proof of its robustness exists. We provide this evidence through sensitivity analyses.

Methods

Data on availability and prices of child medicines from ten historical datasets were combined to create datasets for analysis: Dataset 1 (medicines selected at random) and Dataset 2 (preference given to available medicines, to better capture affordability of medicines). A base case scenario and univariate sensitivity analyses were performed to test critical components of the methodology, including the new variable of numbe

SUBMITTER: Joosse IR 

PROVIDER: S-EPMC10239173 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature